You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/19/22 | 8-K | Current report filing |
|
   |
7 |
| 01/18/22 | 8-K | Current report filing |
|
|
5 |
| 12/30/21 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
6 | |
| 12/21/21 | 8-A12B | Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) |
|
7 | |
| 12/21/21 | 8-K | Current report filing |
|
|
92 |
| 12/21/21 | 15-12B | Notice of termination of registration of a class of securities under Section 12(b) |
|
2 | |
| 12/09/21 | 8-K | Current report filing |
|
|
5 |
| 12/01/21 | 8-K | Current report filing |
|
|
36 |
| 11/16/21 | 8-K | Current report filing |
|
|
6 |
| 11/10/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
80 |
